| MAN JAPAN COREALPHA EQUITY I H CHF | RVI JAPÓN | 43,38% | 117,72% | 268,82% | 397,07% |
| JPM FUNDS-EMERGING MARKETS EQUITY PLUS I (ACC) EUR | RVI EMERGENTES | 43,37% | 88,01% | 64,83% | · |
| AMUNDI FUNDS ASIA EQUITY FOCUS A EUR (C) | RVI ASIA EX-JAPÓN | 43,36% | 79,34% | 47,14% | 113,51% |
| ROBECO EMERGING MARKETS EQUITIES F EUR | RVI EMERGENTES | 43,36% | 82,15% | 66,82% | 163,66% |
| ROBECO EMERGING MARKETS EQUITIES F USD | RVI EMERGENTES | 43,36% | 82,80% | 66,46% | 163,66% |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO I (SNAP) GBP CAP | RVI EMERGENTES | 43,35% | 79,63% | 54,91% | · |
| DWS ESG BIOTECH LC | RVI BIOTECNOLOGÍA | 43,34% | 49,72% | 32,48% | 113,65% |
| ABRDN SICAV I-EMERGING MARKETS SDG EQUITY FUND X ACC EUR | RVI EMERGENTES | 43,33% | 69,84% | 38,29% | · |
| PRIVILEDGE - AMERICAN CENTURY EMERGING MARKETS EQUITY (USD) MX1 CAP | RVI EMERGENTES | 43,33% | 84,67% | · | · |
| T.ROWE CHINA EVOLUTION EQUITY FUND S | RVI CHINA | 43,33% | 80,45% | · | · |
